Empagliflozin for the treatment of nonalcoholic steatohepatitis in patients with type 2 diabetes mellitus

• Main Authors: Lai, Lee-Lee, Vethakkan, Shireene Ratna, Nik Mustapha, Nik Raihan, Mahadeva, Sanjiv, Chan, Wah-Kheong
• Format: Article
• Published: Springer 2020
• Subjects: R Medicine
• Online Access: http://eprints.um.edu.my/36924/

Background and Aims Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a novel class of drugs that lower glucose by inducing renal glycosuria. We aimed to explore whether SGLT2 inhibitor added to the usual care for patients with type 2 diabetes mellitus (T2DM) and biopsy-proven nonalcoholic steat...